Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other ...

Are your everyday habits damaging your liver? It’s not just alcohol – even sugar, painkillers, and sitting too much can take ...

Sarepta Therapeutics on Sunday said there had been a second reported case of acute liver failure resulting in death after a patient received the company's gene therapy for a rare form of muscular ...

Just weeks after beginning the supplement in late February, she began experiencing symptoms she couldn’t ignore — yellowing ...

A second patient with Duchenne muscular dystrophy has died from acute liver failure after receiving the gene therapy Elevidys ...

The only option left for the doctors was liver transplantation and Anakendu's mother came to her rescue by volunteering to ...

Sarepta Therapeutics shares dived 42% in premarket trading after the company disclosed a second reported case of acute liver failure that resulted in a death tied to its Duchenne muscular dystrophy ...

The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.

(NASDAQ:SRPT) plunged to $19.91, down $16.27, or almost 45%, on word of a second death by acute liver failure (ALF) with Elevidys (delandistrogene moxeparvovec), the approved gene therapy for patients ...

Beetroot juice is often called a liver detox drink, but can it really reverse fatty liver? We got in touch with an expert who ...

Shares of Sarepta Therapeutics closed down as much as 42% to hit a nine-year low of $18.30 on Monday after a second death of ...

Sarepta Therapeutics Inc. plummeted after reporting a second patient died of acute liver failure while being treated with its gene therapy for a rare muscle disorder.The death of the 15-year-old boy ...